Blog
Urban Outfitters (URBN) Earnings Expected to Grow: Should You Buy?
The market expects Urban Outfitters (URBN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus
Plus Therapeutics (PSTV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Plus Therapeutics (PSTV) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook
Analysts Estimate Target (TGT) to Report a Decline in Earnings: What to Look Out for
Wall Street expects a year-over-year decline in earnings on lower revenues when Target (TGT) reports results for the quarter ended April 2025. While this widely-known consensus outlook is important
Analysts Estimate Lowe's (LOW) to Report a Decline in Earnings: What to Look Out for
Lowe's (LOW) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook gives a good
Domo (DOMO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Wall Street expects a year-over-year increase in earnings on lower revenues when Domo (DOMO) reports results for the quarter ended April 2025. While this widely-known consensus outlook is important
Analysts Estimate Zoom Communications (ZM) to Report a Decline in Earnings: What to Look Out for
Zoom Communications (ZM) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2025. This widely-known consensus outlook
Expeditors Rewards Shareholders With 5.5% Dividend Hike
In a shareholder-friendly move, Expeditors International of Washington, Inc. EXPD has announced a hike in its dividend payout. Expeditors’ board of directors has approved a dividend hike of 5.5%
Wall Street Analysts Think Zymeworks (ZYME) Could Surge 83.89%: Read This Before Placing a Bet
Zymeworks Inc. (ZYME) closed the last trading session at $11.61, gaining 6.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect?
Shares of Edgewise Therapeutics, Inc. (EWTX) have gained 14.4% over the past four weeks to close the last trading session at $14.89, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 195.05% Upside in Trevi Therapeutics (TRVI): Can the Stock Really Move This High?
Shares of Trevi Therapeutics, Inc. (TRVI) have gained 4.1% over the past four weeks to close the last trading session at $6.46, but there could still be a solid upside left in the stock if
Wall Street Analysts See a 40.5% Upside in Sangoma Technologies Corporation (SANG): Can the Stock Really Move This High?
Sangoma Technologies Corporation (SANG) closed the last trading session at $5.95, gaining 29.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
Wall Street Analysts Believe Xperi (XPER) Could Rally 118.82%: Here's is How to Trade
Xperi (XPER) closed the last trading session at $8.34, gaining 27.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts See a 161.51% Upside in uniQure (QURE): Can the Stock Really Move This High?
uniQure (QURE) closed the last trading session at $12.81, gaining 32.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Think Crexendo (CXDO) Could Surge 42.86%: Read This Before Placing a Bet
Crexendo (CXDO) closed the last trading session at $5.81, gaining 24.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Pagaya Technologies Ltd. (PGY) Could Rally 51.67%: Here's is How to Trade
Pagaya Technologies Ltd. (PGY) closed the last trading session at $14.96, gaining 49.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets
Wall Street Analysts Believe Janus International Group (JBI) Could Rally 27.06%: Here's is How to Trade
Janus International Group, Inc. (JBI) closed the last trading session at $8.50, gaining 35.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price
After Golden Cross, Allient (ALNT)'s Technical Outlook is Bright
After reaching an important support level, Allient Inc. (ALNT) could be a good stock pick from a technical perspective. ALNT recently experienced a "golden cross" event, which saw its 50-day simple
Should You Buy Amphenol (APH) After Golden Cross?
Amphenol Corporation (APH) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, APH's 50-day simple moving average broke out above its
Here's Why Rigel (RIGL) Is a Great 'Buy the Bottom' Stock Now
The price trend for Rigel Pharmaceuticals (RIGL) has been bearish lately and the stock has lost 6.5% over the past two weeks. However, the formation of a hammer chart pattern in its last trading
Air Lease (AL) Now Trades Above Golden Cross: Time to Buy?
Air Lease Corporation (AL) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, AL's 50-day simple moving average crossed above
Babcock International Group (BCKIY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Shares of Babcock International Group PLC (BCKIY) have been struggling lately and have lost 9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could
Why The Charles Schwab Corporation (SCHW) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Here's Why MercadoLibre (MELI) is a Strong Momentum Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The research service
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service


